Please assess the completion status of the following clinical trial:

Trial Title: The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and Stenoses

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patient is at least 18 years old~* Patient has clinical manifestations (i.e. symptoms and/or signs) of chronic DVT of an extremity. The Venous Clinical Severity Score (VCSS) will be used to determine if the patient is currently suffering from chronic DVT, with a VCSS score of 4 or greater necessary for inclusion.~* Imaging confirmation of venous occlusion or stenosis (\>50%) involving the femoral, and/or popliteal veins~* Obstructed vessel caliber can accommodate a 7FR System, from insertion site to target segment~* Patient is able to read and answer a questionnaire in English~Exclusion Criteria:~* History of life-threatening reaction to contrast material~* Unwilling or unable to provide informed consent, or return for required follow-up evaluations~* Participating in another investigational study that has not completed follow-up testing~* Cannot receive outpatient anticoagulation such as LMWH and/or vitamin K antagonists (VKAs)~* Absolute contraindication to contrast media or renal insufficiency (baseline creatinine \>2.0 mg/dL).~* Either a history or presence of heparin-induced thrombocytopenia antibodies

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Venous Stent Arm (Type: EXPERIMENTAL): The study is a single treatment arm study and the venous stent will be placed in all eligible participants.

Based on this trial design, predict the completion outcome and termination type (if applicable).